Status:
RECRUITING
Rapid Molecular Diagnosis and Detection of Emerging Infectious Diseases in Patients With Tropical Fever (Tropifever)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Infectious Diseases in Febrile Patients Returning From Tropical Countries
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Travellers returning from tropical countries often present to emergency departments with acute fever. While systematic screening for malaria is well established in clinical practice in France, further...
Detailed Description
Frequently, travelers returning from tropical countries seek medical advice in the emergency department (ED) for acute fever. While the systematic search for malaria is well anchored in clinical pract...
Eligibility Criteria
Inclusion
- Adult (age ≥ 18 years old)
- Fever (tympanic temperature above 38°c measured in the emergency department)
- Within 28 days of returning from tropical countries (Sub-Saharan Africa, South and Southeast Asia, Central and South America)
- No sepsis (qSOFA \< 2)
Exclusion
- Patient requiring hospitalization
- Patient unable to consent: unconscious or language barrier without an available translator
- Patient under legal protection measure (guardianship, curatorship, legal protection, deprivation of liberty, hospitalisation for psychiatric care)
- Patient refusing to participate
Key Trial Info
Start Date :
August 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
564 Patients enrolled
Trial Details
Trial ID
NCT06539325
Start Date
August 26 2024
End Date
December 1 2026
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service des Urgences
Paris, Paris, France, 75018